Ingvild Farnes

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer.

Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer.

Journal: Scandinavian journal of gastroenterology

Published: November 14, 2025

Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Journal: Cancers

Published: May 27, 2025

ASO Author Reflections: From BRPC to LAPC-Rethinking Resectability in Pancreatic Cancer.

ASO Author Reflections: From BRPC to LAPC-Rethinking Resectability in Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: May 22, 2025

Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial.

Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial.

Journal: Annals of surgical oncology

Published: October 02, 2024

Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer.

Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer.

Journal: Frontiers in oncology

Published: August 30, 2024

Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study.

Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study.

Journal: Scandinavian journal of gastroenterology

Published: July 03, 2024

Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study.

Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study.

Journal: Scandinavian journal of gastroenterology

Published: December 21, 2023

Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).

Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).

Journal: BJS open

Published: September 09, 2023

Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery - A systematic review.

Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery - A systematic review.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: August 20, 2020

Management of gastric conduit retention following hybrid and minimally invasive esophagectomy for esophageal cancer: Two retrospective case series.

Management of gastric conduit retention following hybrid and minimally invasive esophagectomy for esophageal cancer: Two retrospective case series.

Journal: International journal of surgery case reports

Published: November 09, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026